Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducted in East China

Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducted in East China

Abstract Background Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related mortality worldwide. Despite significant advancements in chemotherapy, targeted therapy, and immunotherapy, the prognosis for advanced NSCLC remains poor. The development of resistance to standard t...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Wei, Yan Zhang, Ying Zheng, Chengxing Ma, Qi Zhao, Yongsheng Wang, Liyun Miao, Jingjing Ding
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Pulmonary Medicine
Subjects:
Anlotinib
Advanced NSCLC
Combination therapy
Efficacy
Safety
Online Access:https://doi.org/10.1186/s12890-025-03635-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12890-025-03635-8

Similar Items